French Pharmaceuticals & Biotech Nano Cap Stocks

Results

0 new

Stocks with a market cap under US$50M.

3 companies

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

ALPHE

€2.00

2.6%

-53.6%

Poxel

Market Cap: €10.9m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases.

POXEL

€0.20

-1.0%

-64.1%

Aton

Market Cap: €9.1m

Operates as a bioscience company in France.

ALTAO

€0.011

-8.3%

25.0%